stanozolol has been researched along with Coronary Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kühlkamp, V; Mewis, C; Seipel, L; Spyridopoulos, I | 1 |
Conkie, JA; Davidson, JF; Walker, ID; Young, P | 1 |
Bondarenko, IP | 1 |
Bielawiec, M; Bodzenta, A; Czestochowska, E; Dabrowski, S; Kiersnowska-Rogowska, B; Kłoczko, J; Lukjan, H; Myśliwiec, M; Tymiński, W | 1 |
Davidson, JF; Lochhead, M; McDonald, GA; McNicol, GP | 1 |
Davidson, JF; McDonald, GA; McNicol, GP | 1 |
Bielawiec, M; Myśliwiec, M; Perzanowski, A | 1 |
Conkie, JA; Davidson, JF; McDonald, GA | 1 |
5 trial(s) available for stanozolol and Coronary Disease
Article | Year |
---|---|
Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
Topics: Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Anabolic Agents; Antithrombins; Clinical Trials as Topic; Coronary Disease; Disseminated Intravascular Coagulation; Ethylestrenol; Fibrinolysis; Humans; Male; Methandriol; Methandrostenolone; Methenolone; Middle Aged; Norethandrolone; Oxymetholone; Stanozolol | 1975 |
[Effect of anabolic steroids on liver function in severe forms of chronic circulatory insufficiency].
Topics: Anabolic Agents; Benzothiadiazines; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Diuretics; Drug Evaluation; Humans; Liver; Liver Function Tests; Methandrostenolone; Sodium Chloride Symporter Inhibitors; Stanozolol; Strophanthins | 1979 |
Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Coronary Disease; Female; Fibrinolysis; Humans; Male; Methandrostenolone; Middle Aged; Myocardial Infarction; Phenformin; Stanozolol; Thrombophlebitis; Varicose Veins | 1986 |
Fibrinolytic enhancement by stanozolol: a double blind trial.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Stanozolol | 1972 |
Fibrinolytic enhancement by stanozolol: a double-blind trial.
Topics: Clinical Trials as Topic; Coronary Disease; Fibrinolysis; Humans; Phenformin; Placebos; Stanozolol | 1972 |
3 other study(ies) available for stanozolol and Coronary Disease
Article | Year |
---|---|
Manifestation of severe coronary heart disease after anabolic drug abuse.
Topics: Adult; Anabolic Agents; Coronary Disease; Humans; Male; Myocardial Infarction; Stanozolol; Substance-Related Disorders; Tachycardia, Ventricular | 1996 |
The influence of some drugs on platelet aggregation and adhesion.
Topics: Administration, Oral; Adult; Aged; Arteriosclerosis Obliterans; Coronary Disease; Densitometry; Drug Therapy, Combination; Esters; Female; Fibrinolysis; Humans; Male; Middle Aged; Nicotinic Acids; Phenformin; Platelet Adhesiveness; Raynaud Disease; Serum Globulins; Solubility; Stanozolol; Theophylline; Thromboangiitis Obliterans | 1972 |
Fibrinolytic enhancement by stanozolol--a two year study.
Topics: Coronary Disease; Fibrin; Fibrinolysis; Humans; Male; Stanozolol | 1972 |